Stock 600535 TASLY PHARMACEUTICAL GROUP CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Tasly Pharmaceutical Group Co., Ltd

Equities

600535

CNE000001C81

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 25/04/2024 BST 		5-day change 1st Jan Change
15.36 CNY +3.09% Intraday chart for Tasly Pharmaceutical Group Co., Ltd +0.20% -9.75%
04-25 Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-16 Tasly Pharmaceutical Group Returns to Profit in 2023 as Operating Income Stays Flat MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Tasly Pharmaceutical Group Returns to Profit in 2023 as Operating Income Stays Flat
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Tasly Pharmaceutical Gets Nod to Trial Stem Cell Therapy
ShuYu Civilian Pharmacy Corp., Ltd. Scraps Plan to Buy Stake in Tasly Pharmaceutical's Two Units
Pharnext : offre pour son candidat médicament dans la maladie de Charcot-Marie-Tooth de type 1A
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Les valeurs à suivre aujourd'hui à la Bourse de Paris - Vendredi 21 juillet 2023
Les valeurs à suivre demain à la Bourse de Paris - Vendredi 21 juillet 2023
Mauna Kea Technologies: chiffre d'affaires en hausse de 77% au 2e trimestre
Mauna Kea Technologies : dévisse après la mise en place d’une ligne de financement en fonds propres
Tasly Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Mauna Kea : s'envole après son chiffre d'affaires trimestriel
Les valeurs à suivre aujourd'hui à la Bourse de Paris - Vendredi 21 avril 2023
Les valeurs à suivre demain à la Bourse de Paris - Vendredi 21 avril 2023
Mauna Kea Technologies: chiffre d'affaires du 1er trimestre en hausse de 121% sur un an
Mauna Kea Technologies: des résultats du quatrième trimestre en ligne avec les attentes
Tasly Pharmaceutical Gets Go Ahead to Launch Clinical Trial of Diabetic Kidney Drug
Mauna Kea Technologies : plus forte hausse du marché SRD à la mi-séance du mardi 8 novembre 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600535 Stock
  4. News Tasly Pharmaceutical Group Co., Ltd
  5. Other languages